The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution

AIDS

Volumn 18, Issue 8, 2004, Pages 1147-1158

  Lambotte, Olivier ^a   Chaix, Marie Laure ^b   Gubler, Brigitte ^c   Nasreddine, Nadine ^a   Wallon, Christine ^a   Goujard, Cécile ^c   Rouzioux, Christine ^b   Taoufik, Yassine ^a,c   Delfraissy, Jean François ^a,c  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

Antiretroviral therapy; CD4 T lymphocyte; HIV drug resistance; HIV reservoir; HIV sequence variability; Virus cell interaction

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; ENVELOPE GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MOLECULAR CLONING; MOLECULAR PHYLOGENY; NEIGHBOR JOINING METHOD; PATIENT SELECTION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROVIRUS; REBOUND; SEQUENCE ANALYSIS; STRUCTURAL GENE; VIRUS ACTIVATION; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS STRAIN; WILD TYPE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DISEASE RESERVOIRS; DRUG RESISTANCE, VIRAL; GENES, ENV; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; PHENOTYPE; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRUS REPLICATION;

EID: 2942618578     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200405210-00008     Document Type: Article

References (35)

1. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
2. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997, 94:13193-13197.
3. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
4. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002, 53:557-593.
5. Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, Macken CA, et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent anti-retroviral therapy. N Engl J Med 1999, 340:1614-1622.
6. Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999, 340:1605-1613.
7. Lambotte O, Taoufik Y, de Goer MC, Wallon C, Goujard C, Delfraissy JF. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000, 23:114-119.
8. Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, et al. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA 2001, 286:196-207.
9. Persaud D, Zhou Y, Siliciano JM, Siliciano RF. Latency in human immunodeficiency virus type 1 infection: no easy answers. J Virol 2003, 77:1659-1665.
10. Ostrowski MA, Chun TW, Justement SJ, Motola I, Spinelli MA, Adelsberger J, et al. Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 1999, 73:6430-6435.
11. Lambotte O, Demoustier A, de Goer MC, Wallon C, Gasnault J, Goujard C, et al. Persistence of replication-competent HIV in both memory and naive CD4 T cell subsets in patients on prolonged and effective HAART. AIDS 2002, 16:2151-2157.
12. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 1998, 95:8869-8873.
13. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999, 5:512-517.
14. Di Mascio M, Dornadula G, Zhang H, Sullivan J, Xu Y, Kulkosky J, et al. In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to < 5 copies per milliliter, with a half-life of 6 months. J Virol 2003, 77:2271-2275.
15. McLean AR, Michie CA. In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci USA 1995, 92:3707-3711.
16. Michie CA, McLean A, Alcock C, Beverley PC. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992, 360:264-265.
17. Pasquier C, Millot N, Njouom R, Sandres K, Cazabat M, Puel J, et al. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001, 94:45-54.
18. Delwart EL, Shpaer EC, Louwagie J, McCutchan FE, Grez M, Rubsamen-Waigmann H, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 1993, 262:1257-1261.
19. Felsenstein. PHYLIP, Phytogeny Inference Package, Version 3.6 (alpha). Seattle: Department of Genetics, University of Washington; 2001.
20. Felsenstein. 'Confidence limits on phylogenies: an approach using the bootstrap.' Evolution 1985, 39:783-791.
21. Milich L, Margolin BH, Swanstrom R. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Virology 1997, 239:108-118.
22. Xiao L, Owen SM, Goldman I, Lal AA, dejong JJ, Goudsmit J, et al. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998, 240:83-92.
23. Fouchier RA, Brouwer M, Broersen SM, Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium- inducing V3 genotype by PCR. J Clin Microbiol 1995, 33:906-911.
24. Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, et al. Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J Infect Dis 2001, 183:36-50.
25. Martinez-Picado J, Frost SD, Izquierdo N, Morales-Lopetegi K, Marfil S, Puig T, et al. Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals. J Virol 2002, 76:12344-12348.
26. Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna CJ, Wong J, Finzi D, et al. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci USA 2000, 97:10948-10953.
27. Gunthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, et al. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol 1999, 73:9404-9412.
28. Haddad DN, Birch C, Middleton T, Dwyer DE, Cunningham AL, Saksena NK. Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells. AIDS 2000, 14:2273-2281.
29. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999, 73:10489-10502.
30. Ramratnam B, Mittler JE, Zhang L, Boden D, Hurley A, Fang F, et al. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 2000, 6:82-85.
31. Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, et al. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J Virol 2002, 76:9481-9492.
32. van Rij RP, Visser JA, van Praag RM, Rientsma R, Prins JM, Lange JM, et al. Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs. J Virol 2002, 76:3054-3058.
33. Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, et al. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. J Clin Invest 2000, 105:995-1003.
34. Zhang L, Chung C, Hu BS, He T, Guo Y, Kim AJ, et al. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest 2000, 106:839-845.
35. Chun TW, Davey RT, Jr., Ostrowski M, Shawn Justement J, Engel D, Mullins JI, et al. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 2000, 6:757-761.